Chepstow-based Creo Medical Group plc, a medical device company focused on the emerging field of surgical endoscopy, has announced the first mentored, in-human use of its Speedboat device has taken place in India.

This announcement follows the framework distribution agreement the company signed with Meditek Systems in September to provide clinical in-country training, mentoring and market seeding in India for Creo's Croma Advanced Energy Platform and suite of products.

Medical staff from six key healthcare institutions across India have completed training as part of Creo's Clinical Education Programme.

The procedures were performed by Dr Amit Maydeo and Dr Gaurav Patil at the Baldota Institute of Digestive Sciences hospital in Mumbai.

As well as India and the US, patients have now been successfully treated using the Speedboat device powered by Creo's Croma Advanced Energy platform in the UK, South Africa and Mainland Europe.

Craig Gulliford, chief executive officer for Creo, said: “We are delighted to hear that the Speedboat device has been rolled out in the BIDS hospital and that the first live procedures have been a success, and are due to be followed by other procedures this week. India is one of the fastest growing healthcare markets in the world and is rapidly evolving in pioneering clinical practice. We look forward to further positive news on the subsequent surgeries.”

Creo was recently named Business of the Year and Innovative Business of the Year at the South Wales Argus Business Awards.